Tag
Bharat Parenterals Limited
3 articles
Bharat Parenterals Q2 FY27 Revenue Up 110.9% YoY
Bharat Parenterals reported Q2 FY27 consolidated revenue of ₹136.3 Cr, up 110.9% YoY, with PAT of ₹11.8 Cr versus a loss of ₹(8.6) Cr in Q2 FY26.
Innoxel Lifesciences, a 55.9% subsidiary, drove profit
Bharat Parenterals Q2 Revenue Doubles to ₹136.3 Cr
Bharat Parenterals reported unaudited Q2 FY27 standalone and consolidated financial results approved by the board on October 29, 2026.
Consolidated revenue surged 110.9% YoY to ₹136.28 Cr with EBITDA
Bharat Parenterals Revises EGM Voting Results Disclosure
Bharat Parenterals submitted revised EGM voting results to rectify shareholder category misclassification between Public-Institutions and Non-Institutions.
Both special resolutions passed unanimously